Acta Diabetologica

, Volume 55, Issue 8, pp 813–819 | Cite as

Rs2227982 and rs2227981 in PDCD1 gene are functional SNPs associated with T1D risk in East Asian

  • Yong Gu
  • Lei Xiao
  • Wei Gu
  • Shu Chen
  • Yingjie Feng
  • Jian Wang
  • Zhixiao Wang
  • Yun Cai
  • Heng Chen
  • Xinyu Xu
  • Yun Shi
  • Mei Zhang
  • Kuanfeng Xu
  • Tao Yang
Original Article



To investigate whether PDCD1 gene polymorphisms are functional, and their associations with T1D risk and related clinical characteristics.


A total of 3060 Chinese Han individuals (1019 T1D patients and 2041 healthy controls) were genotyped for 4 tag single nucleotide polymorphisms (SNPs) within the PDCD1 region (rs2227982, rs7421861, rs10204525, and rs6710479) and another most studied synonymous SNP, rs2227981. In addition, 251 healthy individuals underwent an oral glucose tolerance test (OGTT); measures of insulin release and sensitivity were estimated from insulinogenic, BIGTT, Matsuda. Further, we performed in silico bioinformatics analysis to explore potential functional annotation of the investigated SNPs in PDCD1 gene.


Both rs2227982 and rs2227981 polymorphisms were associated with T1D risk in Chinese Han population under additive model (OR = 0.84, 95% CI 0.75–0.93 and OR = 1.23, 95% CI 1.08–1.40, respectively), but not the other three SNPs in PDCD1 gene. Our meta-analysis revealed that rs2227982 and rs2227981 polymorphisms also have significant associations with T1D risk in East Asians (OR = 0.82, 95% CI 0.74–0.90 and OR = 1.23, 95% CI 1.12–1.36, respectively), but not Europeans. And the T allele of rs2227982 polymorphism is associated with increased 30 min post OGTT glucose level (P = 0.023) and 120 min post OGTT insulin level (P = 0.033). Furthermore, the genetic and regulatory architecture suggested all the 5 investigated SNPs in PDCD1 are putatively functional.


Both rs2227982 and rs2227981 polymorphisms were associated with T1D risk in East Asians, and rs2227982 also had a significant association with glycemic traits, which suggested PDCD1 gene polymorphisms might participate in facilitating T1D risk.


Type 1 diabetes PDCD1 Polymorphism 



We wish to thank Dr. Meng Zhu at Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, for his suggestions on the manuscript.

Author contributions

TY directed the study design, and critical revision of the manuscript. KX directed the study design, performed statistical analysis and interpretation of data, and drafted the initial manuscript. YG, WG, ZW, YC, YS and MZ contributed to collection and selection of samples. LX and SC were responsible for analysis and interpretation of data. JW reviewed and commented on various versions of the paper, and suggested revisions. All the co-authors gave final approval of the version.


The study was supported by Grants from the National Natural Science Foundation of China (81670715 and 81270897), Key Program of National Natural Science Foundation of China (81530026), the National Key Project of Research and Development Plan (2016YFC1305000), Jiangsu Province Youth Medical talents Project (QNRC2016584), the Jiangsu Province Key Science and Technology Development Project (BE2017753), Jiangsu Provincial Special Program of Medical Science (BL2012026), the Natural Science Foundation of Jiangsu province (BK2012486), Jiangsu Government Scholarship for Overseaas Studies (JS-2013-260), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).

Compliance with ethical standards

Conflict of interest

The authors declare that there is no duality of interest associated with this manuscript.

Ethical approval

The study was approved by the Ethics Committee of the First Affiliated Hospital of Nanjing Medical University and carried out in agreement with the Helsinki II Declaration as revised in 2000.

Informed consent

Informed consent was obtained from all participants and/or their guardians in a written way.

Supplementary material

592_2018_1152_MOESM1_ESM.doc (494 kb)
Supplementary material 1 (DOC 494 KB)


  1. 1.
    Wållberg M, Cooke A (2013) Immune mechanisms in type 1 diabetes. Trends Immunol 34:583–591CrossRefPubMedGoogle Scholar
  2. 2.
    Nejentsev S, Howson JM, Walker NM, Szeszko J, Field SF, Stevens HE et al (2007) Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450:887–892CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Pociot F, Lernmark Å (2016) Genetic risk factors for type 1 diabetes. Lancet 387:2331–2339CrossRefPubMedGoogle Scholar
  4. 4.
    Todd JA (2006) Statistical false positive or true disease pathway ? Nat Genet 38:731–733CrossRefPubMedGoogle Scholar
  5. 5.
    Sharpe AH, Freeman GJ (2002) The B7-CD28 superfamily. Nat Rev Immunol 2:116–226CrossRefPubMedGoogle Scholar
  6. 6.
    Chen L, Flies DB (2013) Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 13:227–242CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Wang J, Yoshida T, Nakaki F, Hiai H, Okazaki T, Honjo T (2005) Establishment of NOD-Pdcd1−/− mice as an efficient animal model of type I diabetes. Proc Natl Acad Sci USA 102:11823–11828CrossRefPubMedGoogle Scholar
  8. 8.
    Rajasalu T, Brosi H, Schuster C, Spyrantis A, Boehm BO, Chen L et al (2010) Deficiency in B7-H1 (PD-L1)/PD-1 coinhibition triggers pancreatic β-cell destruction by insulin-specific, murine CD8 T-cells. Diabetes 59:1966–1973CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Pauken KE, Jenkins MK, Azuma M, Fife BT (2013) PD-1, but not PD-L1, expressed by islet-reactive CD4+ T cells suppresses infiltration of the pancreas during type 1 diabetes. Diabetes 62:2859–2869CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Nielsen C, Hansen D, Husby S, Jacobsen BB, Lillevang ST (2003) Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes. Tissue Antigens 62:492–497CrossRefPubMedGoogle Scholar
  11. 11.
    Cooper JD, Smyth DJ, Bailey R, Payne F, Downes K, Godfrey LM et al (2007) The candidate genes TAF5L, TCF7, PDCD1, IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes. BMC Med Genet 8:71CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Fawwaz S, Nikamo P, Törn C, Landin-Olsson M, Lernmark A, Alarcón-Riquelme M (2007) No evidence of association of the PDCD1 gene with Type 1 diabetes. Diabet Med 24:1473–1477CrossRefPubMedGoogle Scholar
  13. 13.
    Hiromine Y, Ikegami H, Fujisawa T, Nojima K, Kawabata Y, Noso S et al (2007) Trinucleotide repeats of programmed cell death-1 gene are associated with susceptibility to type 1 diabetes mellitus. Metabolism 56:905–909CrossRefPubMedGoogle Scholar
  14. 14.
    Ni R, Ihara K, Miyako K, Kuromaru R, Inuo M, Kohno H et al (2007) PD-1 gene haplotype is associated with the development of type 1 diabetes mellitus in Japanese children. Hum Genet 121:223–232CrossRefPubMedGoogle Scholar
  15. 15.
    Fichna M, Zurawek M, Januszkiewicz-Lewandowska D, Fichna P, Nowak J (2010) PTPN22, PDCD1 and CYP27B1 polymorphisms and susceptibility to type 1 diabetes in Polish patients. Int J Immunogenet 37:367–372CrossRefPubMedGoogle Scholar
  16. 16.
    Lempainen J, Ilonen J (2012) Influence of type 1 diabetes genes on disease progression: similarities and differences between countries. Curr Diabetes Rep 12:447–455CrossRefGoogle Scholar
  17. 17.
    The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26(S1):1183–1197Google Scholar
  18. 18.
    Liu J, Bian L, Ji L, Chen Y, Chen H, Gu Y et al (2016) The heterogeneity of islet autoantibodies and the progression of islet failure in type 1 diabetic patients. Sci China Life Sci 59:930–939CrossRefPubMedGoogle Scholar
  19. 19.
    Xu K, Jiang L, Zhang M, Zheng X, Gu Y, Wang Z et al (2016) Type 2 diabetes risk allele UBE2E2 is associated with decreased glucose-stimulated insulin release in elderly Chinese Han individuals. Medicine 95:e3604CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96:434–442CrossRefPubMedGoogle Scholar
  21. 21.
    Prokunina L, Castillejo-López C, Oberg F, Gunnarsson I, Berg L, Magnusson V et al (2002) A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 32:666–669CrossRefPubMedGoogle Scholar
  22. 22.
    Kroner A, Mehling M, Hemmer B, Rieckmann P, Toyka KV, Mäurer M et al (2005) A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann Neurol 58:50–57CrossRefPubMedGoogle Scholar
  23. 23.
    Newby PR, Roberts-Davies EL, Brand OJ, Heward JM, Franklyn JA, Gough SC et al (2007) Tag SNP screening of the PDCD1 gene for association with Graves’ disease. Clin Endocrinol 67:125–128CrossRefGoogle Scholar
  24. 24.
    Ishizaki Y, Yukaya N, Kusuhara K, Kira R, Torisu H, Ihara K et al (2010) PD1 as a common candidate susceptibility gene of subacute sclerosing panencephalitis. Hum Genet 127:411–419CrossRefPubMedGoogle Scholar
  25. 25.
    Lee YH, Bae SC, Kim JH, Song GG (2015) Meta-analysis of genetic polymorphisms in programmed cell death 1. Associations with rheumatoid arthritis, ankylosing spondylitis, and type 1 diabetes susceptibility. Z Rheumatol 74:230–239CrossRefPubMedGoogle Scholar
  26. 26.
    Fløyel T, Kaur S, Pociot F (2015) Genes affecting β-cell function in type 1 diabetes. Curr Diabetes Rep 15:97CrossRefGoogle Scholar
  27. 27.
    Fløyel T, Brorsson C, Nielsen LB, Miani M, Bang-Berthelsen CH, Friedrichsen M et al (2014) CTSH regulates β-cell function and disease progression in newly diagnosed type 1 diabetes patients. Proc Natl Acad Sci USA 111:10305–10310CrossRefPubMedGoogle Scholar
  28. 28.
    Dong W, Gong M, Shi Z, Xiao J, Zhang J, Peng J (2016) Programmed cell death-1 polymorphisms decrease the cancer risk: a meta-analysis involving twelve case–control studies. PLoS One 11:e0152448CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Mamat U, Arkinjan M (2015) Association of programmed death-1 gene polymorphism rs2227981 with tumor: evidence from a meta analysis. Int J Clin Exp Med 8:13282–13288PubMedPubMedCentralGoogle Scholar
  30. 30.
    Fujisawa R, Haseda F, Tsutsumi C, Hiromine Y, Noso S, Kawabata Y et al (2015) Low programmed cell death-1 (PD-1) expression in peripheral CD4(+) T cells in Japanese patients with autoimmune type 1 diabetes. Clin Exp Immunol 180:452–457CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Plagnol V, Howson JM, Smyth DJ, Walker N, Hafler JP, Wallace C et al (2011) Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet 7:e1002216CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Hermann R, Lipponen K, Kiviniemi M, Kakko T, Veijola R, Simell O (2006) Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes. Diabetologia 49:1198–1208CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia S.r.l., part of Springer Nature 2018

Authors and Affiliations

  • Yong Gu
    • 1
  • Lei Xiao
    • 1
  • Wei Gu
    • 2
  • Shu Chen
    • 1
  • Yingjie Feng
    • 1
  • Jian Wang
    • 3
  • Zhixiao Wang
    • 1
  • Yun Cai
    • 1
  • Heng Chen
    • 1
  • Xinyu Xu
    • 1
  • Yun Shi
    • 1
  • Mei Zhang
    • 1
  • Kuanfeng Xu
    • 1
  • Tao Yang
    • 1
  1. 1.Department of EndocrinologyThe First Affiliated Hospital of Nanjing Medical UniversityNanjingChina
  2. 2.Department of EndocrinologyThe Affiliated Nanjing Children’s Hospital of Nanjing Medical UniversityNanjingChina
  3. 3.Department of EndocrinologyNanjing General Hospital of Nanjing Military CommandNanjingChina

Personalised recommendations